The healthcare industry is facing significant financial challenges as new tariffs reshape the medical equipment landscape. With U.S. tariff implementations in 2025, targeting imports from key manufacturing countries, hospitals and healthcare facilities are bracing for cost increases of 15-30% on new medical equipment [1]. This economic pressure is forcing healthcare providers to reconsider their procurement strategies, with refurbished medical imaging equipment emerging as a strategic alternative, particularly for higher-cost equipment such as CT, MRI, PET, Ultrasound, and other medical imaging equipment. This report examines how the current tariff environment creates challenges and opportunities for healthcare facilities, and why investing in refurbished medical devices represents a prudent approach to maintaining quality care while managing costs effectively.
The Current Tariff Landscape and Its Impact on Healthcare
The medical imaging equipment industry has entered a period of significant economic uncertainty following the announcement of the tariffs. In early 2025, the Trump administration imposed a 10%minimum tariff on imports, with tariffs on Chinese goods reaching as high as 125% [2][3]. Though a 90-dayreprieve was granted for some sectors, the healthcare industry remains concerned about long-term implications [2]. These tariffs are directly affecting the complex global supply chain that medical device manufacturers rely upon for components, raw materials, and finished products.
Scale and Scope of Tariff Impact
The medical equipment sector is particularly vulnerable to tariffs due to its reliance on international sourcing. Many U.S.-based manufacturers depend on imported electronic components, fully manufactured medical imaging equipment, parts, and accessories from China, Taiwan, Southeast Asia, and other regions [3][1]. According to recent analyses, tariffs on imported medical goods could increase prices by 15-30%, creating substantial budgetary challenges for healthcare providers already operating on thin margins [1]. Major healthcare organizations have recognized this threat, with the American Hospital Association petitioning for exemptions on medical devices, pharmaceutical products, and other healthcare essentials [2][4]. Their concern extends beyond simple cost increases to potential shortages of critical technologies that could interfere with surgeries and patient monitoring [4].
Supply Chain Disruptions
Beyond direct cost increases, the tariffs are causing significant supply chain disruptions. Medical device companies are scrambling to find alternative suppliers or shift manufacturing to tariff-exempt regions, leading to delays in product availability [3]. As Willy Shih, a professor at Harvard Business School, noted, "We live in an interdependent world, and if we want to break those interdependencies, it is not going to happen overnight" [4]. This uncertainty means additional costs and potential delays in acquiring essential medical equipment.
Financial Strain on Healthcare Facilities
The financial implications of these tariffs extend throughout the healthcare ecosystem, creating multi-faceted challenges for hospitals and healthcare facilities.
Budgetary Constraints and Cost Absorption
Hospitals are already operating under tight budget constraints, and the sudden introduction of tariffs is straining financial resources further [5]. Many facilities will be forced to either absorb these additional costs—potentially impacting other areas of patient care—or pass them along to patients and payers, further contributing to rising healthcare costs [4]. Ash Shehata, healthcare sector leader at KPMG, described the situation as a "pressure test" for healthcare's supply chain, noting that "Medical device costs have been rising for years, and tariffs add to that" [2]. The financial strain is particularly acute for smaller and rural hospitals that often operate with minimal financial reserves.
Impacts on Innovation and R&D
Perhaps most concerning for the long-term health of the medical device industry is the potential impact on research and development. As companies allocate more resources to managing supply chain disruptions and regulatory compliance, less funding remains available for innovation [3]. Industry experts worry that "R&D expenditures and investments in innovation and acquiring new technologies may be the easiest place for a company to cut if they're really concerned about the near term".
Refurbished Medical Equipment as a Strategic Solution
In this challenging economic environment, refurbished and reprocessed medical equipment offers a practical alternative that can help healthcare facilities manage costs while maintaining quality care.
Cost Advantages of Refurbished Equipment
Refurbished medical devices have long been recognized as a cost-effective alternative to new equipment, typically offering savings of 40-60% compared to new devices [6][7]. Even with tariffs potentially affecting some refurbished equipment imports, the significant baseline price difference means these devices remain economically advantageous [5]. Many hospitals were already turning to refurbished or reprocessed medical devices as a cost-containment strategy prior to the current tariff situation [6]. The additional pressure from tariffs makes this approach even more compelling, particularly for equipment with long operational lifespans and established refurbishment protocols.
Supply Chain Resilience
One key advantage of the refurbished equipment market is its potential for greater supply chain resilience. While new equipment manufacturing is heavily dependent on global supply chains for components and raw materials, refurbished equipment already exists within the USA [7]. This nullifies any effects of tariffs supply chain disruptions. As international tensions and trade policies continue to evolve, purchasing refurbished equipment represents a strategic advantage for healthcare facilities seeking to ensure continued access to essential equipment [5].
Implementing a Refurbished Equipment Strategy
Healthcare facilities looking to leverage refurbished equipment as part of their tariff mitigation strategy need to implement systematic approaches to procurement and management. Before implementing any new procurement strategy, hospitals should evaluate their current supply chain for medical equipment [6]. This assessment should include analyzing supplier relationships, pricing structures, and reliance on imported equipment. Understanding these vulnerabilities is the first step in developing a more resilient approach.
Quality Assurance Considerations
While cost savings are important, ensuring the quality and safety of refurbished medical equipment remains paramount. Healthcare facilities must develop robust protocols for evaluating refurbished equipment, including:
- Compliance with regulatory standards, such as ISO:13485 certified Quality Management Systems
- Testing and validation procedures
- Warranty
- Ability to service, train and provide parts through the life of the equipment
Concerns have been raised that cost pressures might lead hospitals to "opt for cheaper alternatives that may not meet the same Quality Standards as new devices" [5]. To mitigate this risk, hospitals should develop clear quality criteria and work with reputable refurbishment providers with established track records.
Balancing New and Refurbished Equipment
A strategic approach involves balancing investments in new and refurbished equipment rather than an all-or-nothing approach. Certain cutting-edge technologies or critically sensitive equipment may still warrant new purchases, while more routine situations are ideal candidates for refurbished alternatives [7].
Long-term Strategic Considerations
Beyond the immediate response to tariffs, healthcare facilities should consider several long-term strategies to enhance resilience and manage equipment costs effectively.
Investment in Technology and Innovation
Paradoxically, while immediate cost pressures might suggest reducing technology investments, strategic technology investments can improve long-term resilience. Hospitals can leverage technology to extend the useful life of existing equipment, improve maintenance protocols, and better track equipment utilization [6]. Advanced asset management systems can help hospitals optimize their equipment portfolios, identifying opportunities for refurbishment rather than replacement and maximizing the return on investment for all medical devices.
Developing Alternative Sourcing Options
Healthcare facilities should explore multiple sourcing options to reduce vulnerability to tariffs and trade disputes. This might include:
- Identifying domestic manufacturers of key equipment
- Establishing relationships with refurbished equipment providers
- Exploring group purchasing arrangements to improve buying power
- Investigating opportunities for equipment sharing or leasing
- Renting equipment for short-term needs
Advocacy and Policy Engagement
Conclusion
Work Cited:
- https://www.med.equipment/blogs/blog-explore-industry-news-announcements-and-resources/how-tariffs-and-fda-cuts-are-reshaping-the-medical-equipment-market
- https://www.fiercehealthcare.com/finance/trump-signs-orders-imposing-10-minimum-tariff-plus-broader-reciprocal-tariffs-and-de
- https://legacymedsearch.com/tariffs-impacting-medical-device/
- https://www.biopharmadive.com/news/tariffs-trump-impact-medical-devices-manufacturing/740040/
- https://www.needle.tube/resources-64/Implications-of-Tariffs-on-Refurbished-and-Reprocessed-Medical-Devices:-Considerations-for-Hospital-Supply-and-Equipment-Management
- https://www.needle.tube/resources-64/Navigating-Potential-Tariff-Impacts-on-Refurbished-Medical-Devices-in-the-US:-Strategies-for-Hospitals
- https://www.needle.tube/resources-64/Managing-Equipment-Costs-in-Healthcare-Facilities:-Effects-of-Tariffs-on-Refurbished-Medical-Devices